Murat Kara MD , Yasin Ceran PhD , Pelin Analay MD , Mahmud Fazıl Aksakal MD , Mahmut Esad Durmuş MD , Tülay Tiftik MD , Beyzanur Çıtır MD , Fatıma Edibe Şener MD , Mehmet Emin Yılmaz MD , Evrim Coşkun MD , Zeliha Ünlü MD , Pelin Yıldırım MD , Eda Gürçay MD , Orhan Güvener MD , Hacer Doğan Varan MD , Eda Çeker MD , Esra Çataltepe MD , Fatih Güngör MD , Özden Özyemişci Taskiran MD , Duygu Keler Külcü MD , Levent Özçakar MD
{"title":"用机器学习驱动的风险评估筛选/诊断肌肉减少症:SARCO X研究。","authors":"Murat Kara MD , Yasin Ceran PhD , Pelin Analay MD , Mahmud Fazıl Aksakal MD , Mahmut Esad Durmuş MD , Tülay Tiftik MD , Beyzanur Çıtır MD , Fatıma Edibe Şener MD , Mehmet Emin Yılmaz MD , Evrim Coşkun MD , Zeliha Ünlü MD , Pelin Yıldırım MD , Eda Gürçay MD , Orhan Güvener MD , Hacer Doğan Varan MD , Eda Çeker MD , Esra Çataltepe MD , Fatih Güngör MD , Özden Özyemişci Taskiran MD , Duygu Keler Külcü MD , Levent Özçakar MD","doi":"10.1016/j.jamda.2025.105683","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Sarcopenia imposes significant morbidity and economic burden on health care systems, underscoring the critical need for early/effective screening and diagnosis. This study aimed to develop a machine learning (ML)-based algorithm to facilitate the screening/diagnosis of sarcopenia.</div></div><div><h3>Design</h3><div>A cross-sectional case-control study.</div></div><div><h3>Setting and Participants</h3><div>This multicenter study enrolled subjects aged ≥45 years.</div></div><div><h3>Methods</h3><div>Demographic data such as age, weight, height, education/exercise status, smoking, and comorbid diseases were obtained. Sarcopenia was diagnosed using the basic and ML-based algorithms, which incorporate low quadriceps muscle mass/thickness, combined with prolonged chair stand test (CST) duration and/or reduced hand grip strength (HGS).</div></div><div><h3>Results</h3><div>Of 5649 participants (1379 males, 24.4%), 1097 of them (19.4%) were sarcopenic. Using the ML-based model, significantly associated factors with sarcopenia were age, weight, height, education level, exercise status, and presence of hypertension and diabetes mellitus. Of the various ML models, the Gradient Boosting Classifier (GBC) demonstrated the highest performance in predicting sarcopenia in the holdout test data. For the ML-augmented algorithm, the recall value was 0.979; the precision value was 0.926, and the accuracy value was 0.980 for making the diagnosis of sarcopenia. When compared with the basic sarcopenia algorithm, the ML-augmented algorithm further decreased the need for HGS and ultrasound by 38.1% and 49.5%, respectively, demonstrating its effectiveness in optimizing sarcopenia diagnosis while minimizing testing required for medical device(s).</div></div><div><h3>Conclusions and Implications</h3><div>The ML-based algorithm significantly reduces the need for testing/imaging in the diagnosis of sarcopenia. It facilitates the identification of sarcopenia particularly in the primary and secondary care settings and decreases the number of individuals who should be referred for further evaluation.</div></div>","PeriodicalId":17180,"journal":{"name":"Journal of the American Medical Directors Association","volume":"26 7","pages":"Article 105683"},"PeriodicalIF":4.2000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Screening/Diagnosing Sarcopenia with Machine Learning–Powered Risk Assessment: The SARCO X Study\",\"authors\":\"Murat Kara MD , Yasin Ceran PhD , Pelin Analay MD , Mahmud Fazıl Aksakal MD , Mahmut Esad Durmuş MD , Tülay Tiftik MD , Beyzanur Çıtır MD , Fatıma Edibe Şener MD , Mehmet Emin Yılmaz MD , Evrim Coşkun MD , Zeliha Ünlü MD , Pelin Yıldırım MD , Eda Gürçay MD , Orhan Güvener MD , Hacer Doğan Varan MD , Eda Çeker MD , Esra Çataltepe MD , Fatih Güngör MD , Özden Özyemişci Taskiran MD , Duygu Keler Külcü MD , Levent Özçakar MD\",\"doi\":\"10.1016/j.jamda.2025.105683\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>Sarcopenia imposes significant morbidity and economic burden on health care systems, underscoring the critical need for early/effective screening and diagnosis. This study aimed to develop a machine learning (ML)-based algorithm to facilitate the screening/diagnosis of sarcopenia.</div></div><div><h3>Design</h3><div>A cross-sectional case-control study.</div></div><div><h3>Setting and Participants</h3><div>This multicenter study enrolled subjects aged ≥45 years.</div></div><div><h3>Methods</h3><div>Demographic data such as age, weight, height, education/exercise status, smoking, and comorbid diseases were obtained. Sarcopenia was diagnosed using the basic and ML-based algorithms, which incorporate low quadriceps muscle mass/thickness, combined with prolonged chair stand test (CST) duration and/or reduced hand grip strength (HGS).</div></div><div><h3>Results</h3><div>Of 5649 participants (1379 males, 24.4%), 1097 of them (19.4%) were sarcopenic. Using the ML-based model, significantly associated factors with sarcopenia were age, weight, height, education level, exercise status, and presence of hypertension and diabetes mellitus. Of the various ML models, the Gradient Boosting Classifier (GBC) demonstrated the highest performance in predicting sarcopenia in the holdout test data. For the ML-augmented algorithm, the recall value was 0.979; the precision value was 0.926, and the accuracy value was 0.980 for making the diagnosis of sarcopenia. When compared with the basic sarcopenia algorithm, the ML-augmented algorithm further decreased the need for HGS and ultrasound by 38.1% and 49.5%, respectively, demonstrating its effectiveness in optimizing sarcopenia diagnosis while minimizing testing required for medical device(s).</div></div><div><h3>Conclusions and Implications</h3><div>The ML-based algorithm significantly reduces the need for testing/imaging in the diagnosis of sarcopenia. It facilitates the identification of sarcopenia particularly in the primary and secondary care settings and decreases the number of individuals who should be referred for further evaluation.</div></div>\",\"PeriodicalId\":17180,\"journal\":{\"name\":\"Journal of the American Medical Directors Association\",\"volume\":\"26 7\",\"pages\":\"Article 105683\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-05-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Medical Directors Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1525861025002002\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Medical Directors Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525861025002002","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
Screening/Diagnosing Sarcopenia with Machine Learning–Powered Risk Assessment: The SARCO X Study
Objectives
Sarcopenia imposes significant morbidity and economic burden on health care systems, underscoring the critical need for early/effective screening and diagnosis. This study aimed to develop a machine learning (ML)-based algorithm to facilitate the screening/diagnosis of sarcopenia.
Design
A cross-sectional case-control study.
Setting and Participants
This multicenter study enrolled subjects aged ≥45 years.
Methods
Demographic data such as age, weight, height, education/exercise status, smoking, and comorbid diseases were obtained. Sarcopenia was diagnosed using the basic and ML-based algorithms, which incorporate low quadriceps muscle mass/thickness, combined with prolonged chair stand test (CST) duration and/or reduced hand grip strength (HGS).
Results
Of 5649 participants (1379 males, 24.4%), 1097 of them (19.4%) were sarcopenic. Using the ML-based model, significantly associated factors with sarcopenia were age, weight, height, education level, exercise status, and presence of hypertension and diabetes mellitus. Of the various ML models, the Gradient Boosting Classifier (GBC) demonstrated the highest performance in predicting sarcopenia in the holdout test data. For the ML-augmented algorithm, the recall value was 0.979; the precision value was 0.926, and the accuracy value was 0.980 for making the diagnosis of sarcopenia. When compared with the basic sarcopenia algorithm, the ML-augmented algorithm further decreased the need for HGS and ultrasound by 38.1% and 49.5%, respectively, demonstrating its effectiveness in optimizing sarcopenia diagnosis while minimizing testing required for medical device(s).
Conclusions and Implications
The ML-based algorithm significantly reduces the need for testing/imaging in the diagnosis of sarcopenia. It facilitates the identification of sarcopenia particularly in the primary and secondary care settings and decreases the number of individuals who should be referred for further evaluation.
期刊介绍:
JAMDA, the official journal of AMDA - The Society for Post-Acute and Long-Term Care Medicine, is a leading peer-reviewed publication that offers practical information and research geared towards healthcare professionals in the post-acute and long-term care fields. It is also a valuable resource for policy-makers, organizational leaders, educators, and advocates.
The journal provides essential information for various healthcare professionals such as medical directors, attending physicians, nurses, consultant pharmacists, geriatric psychiatrists, nurse practitioners, physician assistants, physical and occupational therapists, social workers, and others involved in providing, overseeing, and promoting quality